CAPZA3
gene geneOn this page
Also known as Gsg3CAPPA3
Summary
CAPZA3 (capping actin protein of muscle Z-line subunit alpha 3, HGNC:24205) is a protein-coding gene on chromosome 12p12.3, encoding F-actin-capping protein subunit alpha-3 (Q96KX2). F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends.
This gene encodes an actin capping protein, one of the F-actin capping protein alpha subunit family. The encoded protein is predominantly localized to the neck region of ejaculated sperm, other immunohistochemical signals were found in the tail and postacrosomal regions. The encoded protein may also form heterodimers of alpha and beta subunits. This protein may be important in determining sperm architecture and male fertility.
Source: NCBI Gene 93661 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_033328
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24205 |
| Approved symbol | CAPZA3 |
| Name | capping actin protein of muscle Z-line subunit alpha 3 |
| Location | 12p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Gsg3, CAPPA3 |
| Ensembl gene | ENSG00000177938 |
| Ensembl biotype | protein_coding |
| OMIM | 608722 |
| Entrez | 93661 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000317658
RefSeq mRNA: 1 — MANE Select: NM_033328
NM_033328
CCDS: CCDS8681
Canonical transcript exons
ENST00000317658 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001276948 | 18738119 | 18739188 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 97.56.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1903 / max 179.3122, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 124564 | 0.0904 | 3 |
| 124565 | 0.0856 | 3 |
| 124563 | 0.0144 | 3 |
Top tissues by expression
101 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.56 | gold quality |
| right testis | UBERON:0004534 | 97.35 | gold quality |
| testis | UBERON:0000473 | 97.16 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.90 | gold quality |
| right lobe of liver | UBERON:0001114 | 60.66 | gold quality |
| skin of abdomen | UBERON:0001416 | 59.52 | gold quality |
| zone of skin | UBERON:0000014 | 58.09 | gold quality |
| skin of leg | UBERON:0001511 | 57.09 | gold quality |
| body of stomach | UBERON:0001161 | 55.32 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 53.90 | gold quality |
| metanephros cortex | UBERON:0010533 | 52.73 | gold quality |
| stomach | UBERON:0000945 | 52.45 | gold quality |
| liver | UBERON:0002107 | 52.16 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 51.34 | gold quality |
| fundus of stomach | UBERON:0001160 | 50.86 | gold quality |
| right coronary artery | UBERON:0001625 | 48.74 | gold quality |
| right uterine tube | UBERON:0001302 | 48.42 | gold quality |
| kidney | UBERON:0002113 | 47.09 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 46.67 | gold quality |
| cortex of kidney | UBERON:0001225 | 44.92 | gold quality |
| gall bladder | UBERON:0002110 | 42.89 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.14 | gold quality |
| cortical plate | UBERON:0005343 | 40.72 | silver quality |
| esophagus mucosa | UBERON:0002469 | 39.61 | gold quality |
| body of pancreas | UBERON:0001150 | 36.76 | gold quality |
| left uterine tube | UBERON:0001303 | 36.56 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.98 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.59 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 30.95 |
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Capping protein alpha3 may play a physiologically important role in sperm architecture as well as in fertility of the human male. (PMID:12029070)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Capza3 | ENSMUSG00000041791 |
| rattus_norvegicus | Capza3 | ENSRNOG00000067096 |
| drosophila_melanogaster | cpa | FBGN0034577 |
| caenorhabditis_elegans | WBGENE00000292 |
Paralogs (2): CAPZA1 (ENSG00000116489), CAPZA2 (ENSG00000198898)
Protein
Protein identifiers
F-actin-capping protein subunit alpha-3 — Q96KX2 (reviewed: Q96KX2)
Alternative names: CapZ alpha-3, Germ cell-specific protein 3
All UniProt accessions (2): Q96KX2, A0A140VKF6
UniProt curated annotations — full annotation on UniProt →
Function. F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the morphogenesis of spermatid.
Subunit / interactions. Component of the F-actin capping complex, composed of a heterodimer of an alpha and a beta subunit. Component of the WASH complex, composed of F-actin-capping protein subunit alpha (CAPZA1, CAPZA2 or CAPZA3), F-actin-capping protein subunit beta (CAPZB), WASH (WASHC1, WASH2P, WASH3P, WASH4P, WASH5P or WASH6P), WASHC2 (WASHC2A or WASHC2C), WASHC3, WASHC4 and WASHC5.
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Expressed exclusively in testis and sperm. Highest expression is found in the neck region of ejaculated sperm with lower levels found in the tail and postacrosome region.
Similarity. Belongs to the F-actin-capping protein alpha subunit family.
RefSeq proteins (1): NP_201585* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002189 | CapZ_alpha | Family |
| IPR017865 | F-actin_cap_asu_CS | Conserved_site |
| IPR037282 | CapZ_alpha/beta | Homologous_superfamily |
| IPR042276 | CapZ_alpha/beta_2 | Homologous_superfamily |
| IPR042489 | CapZ_alpha_1 | Homologous_superfamily |
Pfam: PF01267
UniProt features (3 total): chain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KX2-F1 | 89.01 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 290
Function
Pathways and Gene Ontology
Reactome pathways
17 pathways
| ID | Pathway |
|---|---|
| R-HSA-2132295 | MHC class II antigen presentation |
| R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand |
| R-HSA-6807878 | COPI-mediated anterograde transport |
| R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
| R-HSA-199977 | ER to Golgi Anterograde Transport |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-2262752 | Cellular responses to stress |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-446203 | Asparagine N-linked glycosylation |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic |
| R-HSA-8856688 | Golgi-to-ER retrograde transport |
| R-HSA-8953897 | Cellular responses to stimuli |
| R-HSA-948021 | Transport to the Golgi and subsequent modification |
MSigDB gene sets: 108 (showing top):
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING, KORKOLA_CHORIOCARCINOMA_DN, GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION, GOBP_MALE_GAMETE_GENERATION, REACTOME_MEMBRANE_TRAFFICKING, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, CAGCTG_AP4_Q5, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, KORKOLA_EMBRYONAL_CARCINOMA_DN
GO Biological Process (6): actin filament organization (GO:0007015), cytoplasm organization (GO:0007028), spermatid development (GO:0007286), actin cytoskeleton organization (GO:0030036), barbed-end actin filament capping (GO:0051016), actin filament capping (GO:0051693)
GO Molecular Function (2): actin filament binding (GO:0051015), actin binding (GO:0003779)
GO Cellular Component (8): nucleus (GO:0005634), cytosol (GO:0005829), F-actin capping protein complex (GO:0008290), membrane (GO:0016020), cortical cytoskeleton (GO:0030863), sperm head (GO:0061827), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-13 pathways:
| Category | Pathways |
|---|---|
| Membrane Trafficking | 2 |
| Adaptive Immune System | 1 |
| Cellular responses to stress | 1 |
| ER to Golgi Anterograde Transport | 1 |
| Golgi-to-ER retrograde transport | 1 |
| Immune System | 1 |
| Transport to the Golgi and subsequent modification | 1 |
| Vesicle-mediated transport | 1 |
| Cellular responses to stimuli | 1 |
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 1 |
| Asparagine N-linked glycosylation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| actin cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| cellular component organization | 1 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| cytoskeleton organization | 1 |
| actin filament-based process | 1 |
| actin filament capping | 1 |
| negative regulation of actin filament depolymerization | 1 |
| negative regulation of actin filament polymerization | 1 |
| actin binding | 1 |
| protein-containing complex binding | 1 |
| cytoskeletal protein binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| actin cytoskeleton | 1 |
| protein-containing complex | 1 |
| cytoskeleton | 1 |
| cell cortex | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1246 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CAPZA3 | TMOD4 | Q9NZQ9 | 963 |
| CAPZA3 | PLCZ1 | Q86YW0 | 625 |
| CAPZA3 | CAPZB | P47756 | 552 |
| CAPZA3 | SPACA1 | Q9HBV2 | 492 |
| CAPZA3 | ROPN1 | Q9HAT0 | 483 |
| CAPZA3 | C22orf23 | Q9BZE7 | 476 |
| CAPZA3 | TSSK1B | Q9BXA7 | 465 |
| CAPZA3 | ACTR6 | Q9GZN1 | 461 |
| CAPZA3 | CABS1 | Q96KC9 | 460 |
| CAPZA3 | GARIN1B | Q96KD3 | 445 |
| CAPZA3 | ACTRT2 | Q8TDY3 | 444 |
| CAPZA3 | ODF1 | Q14990 | 431 |
| CAPZA3 | DPY19L2 | Q6NUT2 | 430 |
| CAPZA3 | FAM170B | A6NMN3 | 427 |
| CAPZA3 | TSSK6 | Q9BXA6 | 421 |
IntAct
0 interactions, top by confidence:
BioGRID (1): CAPZA3 (Proximity Label-MS)
ESM2 similar proteins: A0A7H0DNF0, A1A5R7, B7F7B9, B9A014, F1MIW6, F4HZD1, F4JLK2, O14138, O14423, O23702, O60106, P0DSU9, P0DSV0, P24915, P34751, P36052, P38960, P49777, P52924, P70190, P86452, Q196W7, Q1L6Q1, Q4R7M8, Q5Q0E6, Q6IND4, Q6TEQ0, Q80HX3, Q80TC5, Q84RQ9, Q8CDS7, Q8CFL8, Q8L7T6, Q8QMP8, Q8V4S4, Q96KX2, Q9BR11, Q9DCE9, Q9FFN9, Q9FFP1
Diamond homologs: A0M8R8, A0M8S9, A0M8V0, A0PFK5, A1X151, A4D7Q3, A4D7S9, A4FUA8, B2GUZ5, O82631, P13022, P13127, P25229, P28495, P28497, P34685, P47753, P47754, P47755, P52907, P70190, P9WF01, Q00PJ7, Q07DV7, Q07DY0, Q07DZ0, Q07E00, Q07E23, Q07E36, Q07E47, Q09YH6, Q09YJ9, Q09YL0, Q09YN4, Q108U5, Q29221, Q2IBA7, Q2IBB9, Q2IBE7, Q2QL78
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
189 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:18738757:A:T | donor_gain | 0.8300 |
| 12:18738801:T:G | donor_gain | 0.5800 |
| 12:18738932:GCTC:G | donor_gain | 0.5800 |
| 12:18738828:G:GT | donor_gain | 0.5600 |
| 12:18738778:G:GT | donor_gain | 0.5500 |
| 12:18738828:G:T | donor_gain | 0.5500 |
| 12:18738779:A:T | donor_gain | 0.5400 |
| 12:18738854:TTCAG:T | donor_loss | 0.5400 |
| 12:18738855:TCAG:T | donor_loss | 0.5400 |
| 12:18738857:AGG:A | donor_loss | 0.5400 |
| 12:18738858:GG:G | donor_loss | 0.5400 |
| 12:18738860:T:G | donor_loss | 0.5300 |
| 12:18738931:GGCTC:G | donor_gain | 0.5200 |
| 12:18738546:A:G | acceptor_gain | 0.5000 |
| 12:18738756:G:GT | donor_gain | 0.5000 |
| 12:18738708:G:GG | donor_gain | 0.4800 |
| 12:18738840:TGCAA:T | acceptor_gain | 0.4700 |
| 12:18738841:GCAAG:G | acceptor_gain | 0.4700 |
| 12:18738842:CAAGC:C | acceptor_gain | 0.4700 |
| 12:18738550:T:G | acceptor_gain | 0.4600 |
| 12:18738652:T:G | acceptor_gain | 0.4500 |
| 12:18738935:C:CG | donor_gain | 0.4500 |
| 12:18738938:A:G | acceptor_gain | 0.4400 |
| 12:18739003:G:GT | donor_gain | 0.4400 |
| 12:18738710:AAGG:A | donor_gain | 0.4300 |
| 12:18738711:AGGA:A | donor_gain | 0.4300 |
| 12:18738712:GGAG:G | donor_gain | 0.4300 |
| 12:18738767:A:T | donor_gain | 0.4300 |
| 12:18738702:TCAA:T | donor_gain | 0.4200 |
| 12:18738843:AAGC:A | acceptor_gain | 0.4200 |
AlphaMissense
1991 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:18738788:T:A | W174R | 0.996 |
| 12:18738788:T:C | W174R | 0.996 |
| 12:18738782:T:C | S172P | 0.993 |
| 12:18739075:G:C | W269C | 0.993 |
| 12:18739075:G:T | W269C | 0.993 |
| 12:18739073:T:A | W269R | 0.992 |
| 12:18739073:T:C | W269R | 0.992 |
| 12:18738542:T:C | F92L | 0.991 |
| 12:18738544:C:A | F92L | 0.991 |
| 12:18738544:C:G | F92L | 0.991 |
| 12:18738515:T:C | F83L | 0.990 |
| 12:18738517:T:A | F83L | 0.990 |
| 12:18738517:T:G | F83L | 0.990 |
| 12:18739042:G:C | R258S | 0.990 |
| 12:18739042:G:T | R258S | 0.990 |
| 12:18738543:T:C | F92S | 0.989 |
| 12:18738790:G:C | W174C | 0.989 |
| 12:18738790:G:T | W174C | 0.989 |
| 12:18738776:T:A | W170R | 0.988 |
| 12:18738776:T:C | W170R | 0.988 |
| 12:18738783:C:T | S172F | 0.985 |
| 12:18738854:T:C | F196L | 0.984 |
| 12:18738856:C:A | F196L | 0.984 |
| 12:18738856:C:G | F196L | 0.984 |
| 12:18738868:C:A | N200K | 0.984 |
| 12:18738868:C:G | N200K | 0.984 |
| 12:18738483:T:C | L72S | 0.983 |
| 12:18738966:A:T | E233V | 0.982 |
| 12:18738347:T:C | F27L | 0.981 |
| 12:18738349:T:A | F27L | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1002777400 (12:18739526 A>G,T), RS1002857290 (12:18738275 C>A,T), RS1002995382 (12:18738563 A>C), RS1004405209 (12:18736817 T>G), RS1006289730 (12:18738035 C>T), RS1006330566 (12:18738229 A>G), RS1006602063 (12:18738928 A>G,T), RS1009057068 (12:18736168 T>A,C), RS1009421336 (12:18737649 C>T), RS1009601724 (12:18736463 A>AT), RS1011167352 (12:18737655 A>C,G), RS1013518420 (12:18736797 A>G), RS1014591179 (12:18736520 T>C), RS1014623736 (12:18736754 G>C), RS1015310479 (12:18736818 T>A)
Disease associations
OMIM: gene MIM:608722 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002111_7 | Personality dimensions | 8.000000e-06 |
| GCST003518_20 | Daytime sleep phenotypes | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004365 | personality trait |
| EFO:0007828 | daytime rest measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| bisphenol A | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.